| Pharmacokinetic and pharmacodynamic properties of oral L‐citrulline and L‐arginine: impact on nitric oxide metabolism E Schwedhelm, R Maas, R Freese, D Jung, Z Lukacs, A Jambrecina, ... British journal of clinical pharmacology 65 (1), 51-59, 2008 | 611 | 2008 |
| Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease C Zoccali, FA Benedetto, R Maas, F Mallamaci, G Tripepi, LS Malatino, ... Journal of the American Society of Nephrology 13 (2), 490-496, 2002 | 498 | 2002 |
| Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community RH Böger, LM Sullivan, E Schwedhelm, TJ Wang, R Maas, EJ Benjamin, ... Circulation 119 (12), 1592-1600, 2009 | 446 | 2009 |
| Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension F Perticone, A Sciacqua, R Maio, M Perticone, R Maas, RH Boger, ... Journal of the American College of Cardiology 46 (3), 518-523, 2005 | 369 | 2005 |
| Urinary 8-iso-Prostaglandin F2α as a Risk Marker in Patients With Coronary Heart Disease: A Matched Case-Control Study E Schwedhelm, A Bartling, H Lenzen, D Tsikas, R Maas, J Brümmer, ... Circulation 109 (7), 843-848, 2004 | 332 | 2004 |
| Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients C Zoccali, F Mallamaci, R Maas, FA Benedetto, G Tripepi, LS Malatino, ... Kidney international 62 (1), 339-345, 2002 | 320 | 2002 |
| Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the … F Schulze, H Lenzen, C Hanefeld, A Bartling, KJ Osterziel, L Goudeva, ... American heart journal 152 (3), 493. e1-493. e8, 2006 | 293 | 2006 |
| The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function R Maas, E Schwedhelm, J Albsmeier, RH Böger Vascular Medicine 7 (3), 213-225, 2002 | 291 | 2002 |
| Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality—an update on patient populations with a wide range of cardiovascular risk RH Böger, R Maas, F Schulze, E Schwedhelm Pharmacological Research 60 (6), 481-487, 2009 | 246 | 2009 |
| Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress E Schwedhelm, R Maas, R Troost, RH Böger Clinical pharmacokinetics 42, 437-459, 2003 | 242 | 2003 |
| Determination of a reference value for NG, NG‐dimethyl‐L‐arginine in 500 subjects F Schulze, R Maas, R Freese, E Schwedhelm, E Silberhorn, RH Böger European journal of clinical investigation 35 (10), 622-626, 2005 | 198 | 2005 |
| Suppression of paroxysmal atrial tachyarrhythmias—results of the SOPAT trial M Patten, R Maas, P Bauer, B Lüderitz, F Sonntag, M Dluzniewski, ... European heart journal 25 (16), 1395-1404, 2004 | 192 | 2004 |
| High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma E Schwedhelm, R Maas, J Tan-Andresen, F Schulze, U Riederer, ... Journal of Chromatography B 851 (1-2), 211-219, 2007 | 189 | 2007 |
| Asymmetric and symmetric dimethylarginine as risk markers for total mortality and cardiovascular outcomes: a systematic review and meta-analysis of prospective studies S Schlesinger, SR Sonntag, W Lieb, R Maas PloS one 11 (11), e0165811, 2016 | 178 | 2016 |
| Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA) R Maas Vascular Medicine 10 (1_suppl), S49-S57, 2005 | 164 | 2005 |
| Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke F Schulze, AM Carter, E Schwedhelm, R Ajjan, R Maas, RA von Holten, ... Atherosclerosis 208 (2), 518-523, 2010 | 148 | 2010 |
| Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients G Tripepi, FM Raso, E Sijbrands, MS Seck, R Maas, R Boger, J Witteman, ... Clinical Journal of the American Society of Nephrology 6 (7), 1714-1721, 2011 | 147 | 2011 |
| Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events TK Krempl, R Maas, K Sydow, T Meinertz, RH Böger, J Kähler European heart journal 26 (18), 1846-1851, 2005 | 141 | 2005 |
| Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension RA Benndorf, T Rudolph, D Appel, E Schwedhelm, R Maas, F Schulze, ... Metabolism 55 (9), 1159-1164, 2006 | 139 | 2006 |
| Adverse drug events in older patients admitted as an emergency: the role of potentially inappropriate medication in elderly people (PRISCUS) H Dormann, A Sonst, F Müller, R Vogler, A Patapovas, B Pfistermeister, ... Deutsches Ärzteblatt international 110 (13), 213, 2013 | 137 | 2013 |
